CoChat

Thermal Proteome Profiling Reveals Meltome Upon NLRP3 Inflammasome Activation

Open access
Yang, Chen, Wang, Ling, Liu, Yuchen, Zhang, Yuehui, Jin, Chaozhi, Cheng, Jiale, Shang, Limin, Fang, Longlong, Wu, Shanshan, Chen, Chuan, Wang, Jian · 2025 · Molecular & Cellular Proteomics

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index; none of the 26 sources its claims cite is checked for support yet.

Abstract

NOD-like receptor (NLR) family pyrin domain containing 3 (NLRP3) involves in inflammasome complex assembly and innate immunity. Activation of the NLRP3 inflammasome induces conformational alterations in protein complexes, influencing their interactions with other molecules, which in turn affects protein thermal stability. To investigate the proteome-wide thermal stability alterations induced by NLRP3 inflammasome activation, we conducted a comprehensive analysis of meltome dynamics using thermal proteome profiling. Our analysis identified 337 proteins exhibiting alterations in thermal stability upon NLRP3 inflammasome activation. Subsequently, we validated three proteins by the cellular thermal shift assay. Notably, our findings reveal that the majority of these proteins tend to cluster into distinct macromolecular complexes. Furthermore, we identified FAM120A as a novel NLRP3 binding partner, with its suppression enhancing caspase-1 activation and IL-1β release in response to NLRP3 agonist. Collectively, these data provide a comprehensive framework for understanding the mechanisms of NLRP3 inflammasome activation and underscore the utility of thermal proteome profiling in exploring proteome-wide thermal stability changes during signaling transduction.

Overview

CoChat Summary

TL;DR

Thermal proteome profiling of iBMDM cells during LPS priming and nigericin-induced NLRP3 inflammasome activation identified 337 proteins with altered thermal stability and nominated FAM120A as a novel NLRP3/ASC interactor. Functional assays showed FAM120A suppresses caspase-1 activation, IL-1β release, and ASC speck formation, identifying it as a negative regulator of NLRP3 inflammasome activation.

Key findings

  • TPP quantified 3544 proteins with stability Z-scores and 2620 with abundance Z-scores; 337 proteins showed thermal stability changes and 179 showed abundance changes, with 20 changing both. Relative to mock, 36 proteins changed thermal stability after LPS priming versus 188 after nigericin activation.
  • Among the 337 stability-altered proteins, 15 had prior links to NLRP3 pathway regulation or components, including USP9X, USP8, PTK2B, ADK, and RIPK3. CETSA validated decreased thermal stability of PTK2B and RAF1 after nigericin and increased thermal stability of NUP98 after LPS priming.
  • AP-MS identified 45 high-confidence NLRP3-associated proteins after LPS stimulation, decreasing to 18 after nigericin; four overlapped with TPP: RAB32, ABHD12, OAS1A, and FAM120A. FAM120A interacted with NLRP3, primarily through the NACHT domain, and with ASC, and colocalized with ASC specks.
  • FAM120A knockdown or knockout enhanced caspase-1 p20 activation, IL-1β secretion, and LDH release; FAM120A overexpression reduced IL-1β maturation and ASC specks (2.58% ASC speck-positive cells in control, 54.08% with Myc-NLRP3, and 33.85% with Myc-NLRP3 plus Flag-FAM120A).

Methods

  • iBMDM or BMDM cells were primed with LPS (1,000 ng/ml for iBMDM; 400 ng/ml for BMDM) for 6 h and stimulated with 10 μM nigericin for 30 min. TPP was performed on cell extracts heated across 10 temperatures from 37 °C to 67 °C, with TMT10 labeling and LC-MS/MS, using two biological replicates per condition.
  • TPP data were analyzed in R using limma, variance stabilization, bootstrap-based abundance and stability scores, z-scores, and local/global FDR cutoffs of 0.01; altered proteins were called at |Z-score| > 1.96 and FDR < 0.05. Downstream analyses included GO enrichment, STRING/Cytoscape networks, and CORUM complex mapping.
  • AP-MS used NLRP3 antibody versus IgG in BMDMs under LPS-primed and nigericin-activated conditions, with three experimental replicates per condition and six control replicates per condition (one control excluded; final dataset: three experimental and eleven control replicates). Validation used CETSA, coimmunoprecipitation, siRNA, CRISPR/Cas9 knockout, qPCR, LDH assays, immunofluorescence, and HEK293T inflammasome reconstitution.

Limitations

  • Stated in the paper: TPP sensitivity is inherently limited, as some protein interactions or ligand-binding events may not significantly alter thermal stability and trace changes are difficult to detect; AP-MS left key components directly implicated in inflammasome assembly unidentified; many identified molecules require further validation and functional studies; and FAM120A’s precise molecular mechanism and clinical applicability need further exploration.
  • Evident from the text: TPP was performed on cell extracts rather than intact cells, and the TPP design used only two biological replicates per condition, which may limit detection of subtle or context-dependent thermal stability changes.
  • Evident from the text: most of the 337 stability-altered proteins were not functionally validated, so their roles in NLRP3 inflammasome activation remain associative rather than causal.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.mcpro.2025.100972

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Graphical abstract
Graphical abstract CC BY · PubMed Central
Fig. 1 Global profiling of abundance and thermostability alterations during NLRP3 inflammasome activation. A, schematic overview of the TPP workflow. B, immunoblot analysis of iBMDM supernatants and lysates following treatment with LPS and nigericin (Nig). C-E, the protein levels in supernatants of control (left), LPS-primed (middle), and nigericin-stimulated cells (right) across a temperature gradient by SDS-PAGE. BMDM, bone marrow-derived macrophage; iBMDM, immortalized BMDM; LPS, lipopolysaccharide; NLRP3, NLR family pyrin domain containing; TPP, thermal proteome profiling.
Fig. 1 Global profiling of abundance and thermostability alterations during NLRP3 inflammasome activation. A, schematic overview of the TPP workflow. B, immunoblot analysis of iBMDM supernatants and lysates following treatment with LPS and nigericin (Nig). C-E, the protein levels in supernatants of control (left), LPS-primed (middle), and nigericin-stimulated cells (right) across a temperature gradient by SDS-PAGE. BMDM, bone marrow-derived macrophage; iBMDM, immortalized BMDM; LPS, lipopolysaccharide; NLRP3, NLR family pyrin domain containing; TPP, thermal proteome profiling.CC BY · PubMed Central
Fig. 2 Characterization of protein abundance and thermostability changes during NLRP3 inflammasome activation. A, Venn diagram illustrating the overlap between proteins with abundance changes and those with altered thermostability in different groups. B, bar graph showing trends in protein abundance and thermostability changes in different groups. C, UpSet plot summarizing proteins with significant abundance and thermostability changes in different groups. D, cellular component (CC) enrichment analysis of proteins with altered thermal stability. E, biological process (BP) enrichment analyses of proteins with altered thermal stability. NLRP3, NLR family pyrin domain containing 3
Fig. 2 Characterization of protein abundance and thermostability changes during NLRP3 inflammasome activation. A, Venn diagram illustrating the overlap between proteins with abundance changes and those with altered thermostability in different groups. B, bar graph showing trends in protein abundance and thermostability changes in different groups. C, UpSet plot summarizing proteins with significant abundance and thermostability changes in different groups. D, cellular component (CC) enrichment analysis of proteins with altered thermal stability. E, biological process (BP) enrichment analyses of proteins with altered thermal stability. NLRP3, NLR family pyrin domain containing 3CC BY · PubMed Central
Fig. 3 Thermal stability profiles of proteins during NLRP3 inflammasome activation. A, hierarchical clustering of log fold changes (logFC) for 204 proteins with decreased thermal stability (z-score <0, q-value <0.05). B, hierarchical clustering of logFC for 133 proteins with increased thermal stability (z-score ≥0, q-value <0.05). NLRP3, NLR family pyrin domain containing 3.
Fig. 3 Thermal stability profiles of proteins during NLRP3 inflammasome activation. A, hierarchical clustering of log fold changes (logFC) for 204 proteins with decreased thermal stability (z-score <0, q-value <0.05). B, hierarchical clustering of logFC for 133 proteins with increased thermal stability (z-score ≥0, q-value <0.05). NLRP3, NLR family pyrin domain containing 3.CC BY · PubMed Central
Fig. 4 Network analysis of proteins with thermal stability changes during NLRP3 inflammasome activation. A, a protein-protein interaction network of 286 proteins exhibiting thermal stability changes, constructed using the STRING database. The network highlights six distinct clusters, each representing functionally related proteins. B, biological process enrichment analyses for the six identified clusters. Each cluster is associated with specific biological processes, with the top three representative processes displayed. C, the network of cocomplex proteins associated with NLRP3 proteins through AP-MS. D, Venn diagram showing the overlap between TPP and AP-MS datasets. E, heatmap of abundance changes of four overlapping proteins identified in (D) during NLRP3 inflammasome activation. AP-MS, affinity purification-mass spectrometry; NLRP3, NLR family pyrin domain containing 3; TPP, thermal proteome profiling.
Fig. 4 Network analysis of proteins with thermal stability changes during NLRP3 inflammasome activation. A, a protein-protein interaction network of 286 proteins exhibiting thermal stability changes, constructed using the STRING database. The network highlights six distinct clusters, each representing functionally related proteins. B, biological process enrichment analyses for the six identified clusters. Each cluster is associated with specific biological processes, with the top three representative processes displayed. C, the network of cocomplex proteins associated with NLRP3 proteins through AP-MS. D, Venn diagram showing the overlap between TPP and AP-MS datasets. E, heatmap of abundance changes of four overlapping proteins identified in (D) during NLRP3 inflammasome activation. AP-MS, affinity purification-mass spectrometry; NLRP3, NLR family pyrin domain containing 3; TPP, thermal proteome profiling.CC BY · PubMed Central
Fig. 5 FAM120A binds to NLRP3. A, coimmunoprecipitation of Myc-tagged NLRP3 with Flag-tagged FAM120A in HEK293T cells, followed by immunoblot analysis. B, immunoprecipitation of NLRP3 from BMDMs treated with LPS or nigericin, analyzed by immunoblotting with indicated antibodies. C, schematic representation of FLAG-tagged NLRP3 constructs: full-length NLRP3, PYD (amino acids 1–219), NACHT (amino acids 220–741), and LRR (amino acids 742–1036). D, coimmunoprecipitation of Flag-tagged FAM120A with Myc-tagged full-length or truncated NLRP3 constructs in HEK293T cells, analyzed by immunoblotting. The coimmunoprecipitation signals were normalized to the relative density of coimmunoprecipitated FAM120A, with quantifications based on triplicate experiments. E, interaction of Myc-tagged ASC with Flag-tagged FAM120A analyzed by co-immunoprecipitation in HEK293T cells. F, endogenous interaction of ASC and FAM120A analyzed by immunoprecipitation in BMDMs. G, confocal imaging of FAM120A (red) and ASC-GFP (green) in HeLa cells transfected with NLRP3 and/or FAM120A. The scale bar represents 10 μm. ASC, apoptosis-associated speck-like protein containing a CARD; BMDM, bone marrow-derived macrophage; LPS, lipopolysaccharide; LRR, leucine-rich repeat domain.
Fig. 5 FAM120A binds to NLRP3. A, coimmunoprecipitation of Myc-tagged NLRP3 with Flag-tagged FAM120A in HEK293T cells, followed by immunoblot analysis. B, immunoprecipitation of NLRP3 from BMDMs treated with LPS or nigericin, analyzed by immunoblotting with indicated antibodies. C, schematic representation of FLAG-tagged NLRP3 constructs: full-length NLRP3, PYD (amino acids 1–219), NACHT (amino acids 220–741), and LRR (amino acids 742–1036). D, coimmunoprecipitation of Flag-tagged FAM120A with Myc-tagged full-length or truncated NLRP3 constructs in HEK293T cells, analyzed by immunoblotting. The coimmunoprecipitation signals were normalized to the relative density of coimmunoprecipitated FAM120A, with quantifications based on triplicate experiments. E, interaction of Myc-tagged ASC with Flag-tagged FAM120A analyzed by co-immunoprecipitation in HEK293T cells. F, endogenous interaction of ASC and FAM120A analyzed by immunoprecipitation in BMDMs. G, confocal imaging of FAM120A (red) and ASC-GFP (green) in HeLa cells transfected with NLRP3 and/or FAM120A. The scale bar represents 10 μm. ASC, apoptosis-associated speck-like protein containing a CARD; BMDM, bone marrow-derived macrophage; LPS, lipopolysaccharide; LRR, leucine-rich repeat domain.CC BY · PubMed Central
Fig. 6 FAM120A inhibits NLRP3 inflammasome activation. A-B, BMDMs treated with control siRNA or Fam120a siRNA were stimulated with mock, LPS, or nigericin. Supernatants (Sup) and lysates were analyzed by immunoblotting with indicated antibodies. Cell viability was measured by LDH assay of supernatants. Error bars represent SD of triplicate repeats. Unpaired two-tailed Student’s t test: ∗, p < 0.05; ∗∗, p < 0.01; ∗∗∗, p < 0.001; ∗∗∗∗, p < 0.0001. C-E, quantification of relative mRNA levels of Fam120a (C), Nlrp3 (D), and Il-1b (E) in Fam120a knockdown BMDMs with mock, LPS, or nigericin-treatment. F-G, NLRP3 inflammasome activation in iBMDMs with control (sg-GFP) or Fam120a KO (sg-Fam120a). Supernatants and lysates were analyzed by immunoblotting. Cell viability was measured by LDH assay of supernatants. Unpaired two-tailed Student’s t test: ∗, p < 0.05; ∗∗, p < 0.01; ∗∗∗, p < 0.001; ∗∗∗∗, p < 0.0001. H, NLRP3 inflammasome was reconstituted in HEK293T cells by coexpressing of Myc-tagged NLRP3, pro-IL-1b, ASC, pro-caspase-1, and increasing amounts of Flag-tagged FAM120A. The cell lysates were analyzed by immunoblotting in whole-cell lysates (WCL) with indicated antibodies. I, ASC-GFP was stably expressed in HEK293T cells. ASC specks were visualized and quantified by fluorescence microscopy of cells transfected with NLRP3 and/or FAM120A. The scale bar represents 100 μm. Error bars represent SD from triplicate replicates. Unpaired two-tailed Student’s t test: ∗∗∗∗, p < 0.0001. ASC, apoptosis-associated speck-like protein containing a CARD; BMDM, bone marrow-derived macrophage; iBMDM, immortalized BMDM; LDH, lactate dehydrogenase; LPS, lipopolysaccharide; NLRP3, NLR family pyrin domain containing 3; siRNA, small interfering RNA.
Fig. 6 FAM120A inhibits NLRP3 inflammasome activation. A-B, BMDMs treated with control siRNA or Fam120a siRNA were stimulated with mock, LPS, or nigericin. Supernatants (Sup) and lysates were analyzed by immunoblotting with indicated antibodies. Cell viability was measured by LDH assay of supernatants. Error bars represent SD of triplicate repeats. Unpaired two-tailed Student’s t test: ∗, p < 0.05; ∗∗, p < 0.01; ∗∗∗, p < 0.001; ∗∗∗∗, p < 0.0001. C-E, quantification of relative mRNA levels of Fam120a (C), Nlrp3 (D), and Il-1b (E) in Fam120a knockdown BMDMs with mock, LPS, or nigericin-treatment. F-G, NLRP3 inflammasome activation in iBMDMs with control (sg-GFP) or Fam120a KO (sg-Fam120a). Supernatants and lysates were analyzed by immunoblotting. Cell viability was measured by LDH assay of supernatants. Unpaired two-tailed Student’s t test: ∗, p < 0.05; ∗∗, p < 0.01; ∗∗∗, p < 0.001; ∗∗∗∗, p < 0.0001. H, NLRP3 inflammasome was reconstituted in HEK293T cells by coexpressing of Myc-tagged NLRP3, pro-IL-1b, ASC, pro-caspase-1, and increasing amounts of Flag-tagged FAM120A. The cell lysates were analyzed by immunoblotting in whole-cell lysates (WCL) with indicated antibodies. I, ASC-GFP was stably expressed in HEK293T cells. ASC specks were visualized and quantified by fluorescence microscopy of cells transfected with NLRP3 and/or FAM120A. The scale bar represents 100 μm. Error bars represent SD from triplicate replicates. Unpaired two-tailed Student’s t test: ∗∗∗∗, p < 0.0001. ASC, apoptosis-associated speck-like protein containing a CARD; BMDM, bone marrow-derived macrophage; iBMDM, immortalized BMDM; LDH, lactate dehydrogenase; LPS, lipopolysaccharide; NLRP3, NLR family pyrin domain containing 3; siRNA, small interfering RNA.CC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 17 Not checked · 96 Own results and interpretations

67 more claims

Create a free account to see all 113 claims and to verify the 26 references still open.

See all claims — free account
  • It may state two separate claims as one. 27
  • Probably not a substantial claim. 24

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 6 · the rest aren’t loaded

1 more finding

Create a free account to see every finding of this check.

See all findings — free account

Citations

Cites

Show all 65 references

Cited by

See all 3

Metadata

Authors
Yang, C., Wang, L., Liu, Y., Zhang, Y., Jin, C., Cheng, J., Shang, L., Fang, L., Wu, S., Chen, C., & Wang, J.
Affiliations
  • Beijing Proteome Research Center (CN)
  • Anhui Medical University (CN)
  • Hebei University (CN)
Corresponding author
Wang, Jian
Venue
Molecular & Cellular Proteomics
Publisher
Elsevier BV
Published
2025-05
Volume
24
Issue
5
Pages
100972
ISSN
1535-9476 (ISSN-L)
OpenAlex
W4409537794
Cited by
3
References
65
Citations by year
2026: 3
FWCI
0.59
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular & Cellular Proteomics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Key Research and Development Program of China
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Keywords
NLRP3 inflammasome, thermal proteome profiling, protein thermal stability, NOD-like receptors, caspase-1 activation, IL-1β release, protein-protein interaction, macromolecular complexes, innate immunity, inflammasome activation
MeSH terms
NLR Family, Pyrin Domain-Containing 3 Protein, Humans, Caspase 1, Proteome, Proteomics, Interleukin-1beta, Protein Stability, HEK293 Cells, Inflammasomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-22, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-22 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.